youtube_live
Q3 2026 earnings • released • Revenue miss -2.03%
See resultschevron_right
ALM:BME
Almirall SA
€10.92
arrow_upward
+1.30%(+0.14) 1D
Nov 12, 11:32:04 AM GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALM...
Open
€10.78
High
€10.94
Low
€10.78
Mkt. cap
2.38B
Avg. vol.
140.20K
Volume
57.95K
Dividend
1.71%
Quarterly dividend
€0.05
Ex-dividend date
May 30, 2017
P/E ratio
39.73
52-wk high
€13.98
52-wk low
€9.81
EPS
€0.27
Shares outstanding
217.78M
No. of employees
2K
Open
€10.78
High
€10.94
Low
€10.78
Mkt. cap
2.38B
Avg. vol.
140.20K
Volume
57.95K
Dividend
1.71%
Quarterly dividend
€0.05
Ex-dividend date
May 30, 2017
P/E ratio
39.73
52-wk high
€13.98
52-wk low
€9.81
EPS
€0.27
Shares outstanding
217.78M
No. of employees
2K
News stories
From web sources and news partners
Yahoo Finance
·
2 days ago
Almirall SA (ALMRY) Q3 2026 Earnings Call Highlights: Strong Dermatology Growth and Early ...
Investing.com
·
3 days ago
Almirall Q3 2026 slides: biologics drive growth despite earnings miss
Investing.com
·
3 days ago
Earnings call transcript: Almirall misses Q3 2026 profit view as sales rise
Yahoo Finance
·
3 days ago
Almirall 9M 2026 Results
Profile
Almirall, S.A. is a Spanish pharmaceutical company dedicated to medical dermatology, with headquarters in Barcelona, founded in 1944.
In 2023, the company generated total revenues of €898.8 million and was the leading European company in medical dermatology.
With approximately 1,904 employees, it has a direct presence in 20 countries through its 15 subsidiaries in Europe and the USA. Wikipedia
About Almirall SA
CEOCarlos Gallardo Piqué | Gianfranco Nazzi
Employees2.1K
Founded1944
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitealmirall.com